Shopping Cart
- Remove All
- Your shopping cart is currently empty
SB-435495 is an orally active, selective and potent Lp-PLA2 inhibitor (IC50 of 0.06 nM) for the study of autoimmune uveitis and atherosclerosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $52 | In Stock | |
2 mg | $74 | In Stock | |
5 mg | $123 | In Stock | |
10 mg | $198 | In Stock | |
25 mg | $455 | In Stock | |
50 mg | $745 | In Stock | |
100 mg | $1,180 | In Stock |
Description | SB-435495 is an orally active, selective and potent Lp-PLA2 inhibitor (IC50 of 0.06 nM) for the study of autoimmune uveitis and atherosclerosis. |
In vitro | SB-435495 inhibits CYP450 3A4 with an IC50 of 10 μM and a membrane permeability of 0.017 cm/h[1]; SB-435495 (5 μM; 24 h) significantly inhibits the expression of Lp-PLA2 protein and simultaneously increases oxLDL-exposed HUVECs. Medium expression levels of AMPKα and phospho-AMPKα (T172); SB-435495 (5 μM; 24-72 h) significantly increased cell viability and NO expression and significantly decreased ET-1 expression in oxLDL-exposed HUVECs[2] . |
In vivo | SB-435495 (10 mg/kg; p.o.; once) inhibits plasma Lp-PLA2 in WHHL rabbit [1].
SB-435495 (10 mg/kg; i.p.; daily for 28 days) effectively inhibits blood retinal barrier (BRB) disruption in Streptozotocin diabetic Brown Norway rats [3]. |
Alias | SB435495, SB 435495 |
Molecular Weight | 720.82 |
Formula | C38H40F4N6O2S |
Cas No. | 304694-39-1 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (110.98 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.